Managed Account Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$15M Sell
607,324
-34,912
-5% -$872K 0.01% 882
2015
Q1
$16.1M Buy
642,236
+54,132
+9% +$1.29M 0.01% 837
2014
Q4
$13.6M Sell
588,104
-27,756
-5% -$635K 0.01% 894
2014
Q3
$14.4M Sell
615,860
-21,348
-3% -$500K 0.02% 835
2014
Q2
$14.7M Sell
637,208
-23,540
-4% -$520K 0.02% 822
2014
Q1
$14.1M Sell
660,748
-136,520
-17% -$3.07M 0.02% 804
2013
Q4
$18.9M Sell
797,268
-39,376
-5% -$853K 0.03% 677
2013
Q3
$16.7M Sell
836,644
-11,196
-1% -$212K 0.02% 687
2013
Q2
$14.6M Buy
+847,840
New +$14.1M 0.02% 708

Other funds holding TECH

Managed Account Advisors's TECH Position: Q2 2015 in Review

Managed Account Advisors reduced its Bio-Techne (TECH) stake by 5.4% in Q2 2015, selling an estimated $872K and leaving 607,324 shares worth $15M. The position accounts for 0.01% of the portfolio, ranked #882.

Managed Account Advisors first reported a position in TECH in Q2 2013 and has held it in 9 quarters since. The position peaked at $18.9M in Q4 2013. 243 funds tracked by Wall St. Rank hold TECH as of Q2 2015.

  • Managed Account Advisors held 607,324 shares of Bio-Techne worth $15M as of Q2 2015.
  • Managed Account Advisors sold 34,912 Bio-Techne shares in Q2 2015, an estimated $872K.
  • Bio-Techne made up 0.01% of Managed Account Advisors's portfolio in Q2 2015, its #882 holding.
  • Managed Account Advisors first reported a position in Bio-Techne in Q2 2013 and has held it in 9 quarters since.
  • Managed Account Advisors's Bio-Techne position peaked at $18.9M in Q4 2013.
  • 243 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.